These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1725633

  • 1. [Future perspectives of bone marrow and stem cell activation for autologous transplantation].
    Gerhartz H.
    Beitr Infusionsther; 1991; 28():254-8. PubMed ID: 1725633
    [Abstract] [Full Text] [Related]

  • 2. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E, Burroughs J, DeFor T, Verfaillie C, Weisdorf D.
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [Abstract] [Full Text] [Related]

  • 3. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
    Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W.
    Exp Hematol; 1990 Feb; 18(2):94-8. PubMed ID: 1968009
    [Abstract] [Full Text] [Related]

  • 4. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R, Murea S.
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [Abstract] [Full Text] [Related]

  • 5. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ, Baars JW, Wijngaarden MJ, van der Schoot CE, Vlasveld LT, Rodenhuis S.
    Ned Tijdschr Geneeskd; 1993 Jan 30; 137(5):245-50. PubMed ID: 7679478
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
    Elfenbein GJ.
    Pediatr Transplant; 2005 Dec 30; 9 Suppl 7():37-47. PubMed ID: 16305616
    [Abstract] [Full Text] [Related]

  • 7. [Clinical use of peripheral stem cells for autologous transplantation].
    Zingsem J, Zeiler T, Weisbach V, Holfeld-Ozuysal C, Zimmermann R, Heuft HG, Beyer J, Schwerdtfeger R, Eckstein R.
    Beitr Infusionsther; 1991 Dec 30; 28():251-3. PubMed ID: 1725632
    [Abstract] [Full Text] [Related]

  • 8. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct 30; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 9. High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
    Vose JM, Armitage JO, Kessinger A.
    Oncology (Williston Park); 1993 Aug 30; 7(8):23-9; discussion 29-30, 33-4. PubMed ID: 8104456
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 30; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 30; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS, Gremba C, Shadduck RK, Zeigler ZR, Nemunaitis J.
    Exp Hematol; 1994 Mar 30; 22(3):290-4. PubMed ID: 7509292
    [Abstract] [Full Text] [Related]

  • 13. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor.
    Boogaerts MA, Demuynck H.
    Eur J Cancer; 1994 Mar 30; 30A Suppl 3():S34-9. PubMed ID: 7535071
    [Abstract] [Full Text] [Related]

  • 14. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K, Raaschou-Jensen K, Andersen H, Russell CA, Vindeløv L, Jacobsen N, Dickmeiss E.
    Bone Marrow Transplant; 1999 Feb 30; 23(3):243-9. PubMed ID: 10084255
    [Abstract] [Full Text] [Related]

  • 15. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
    Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pförsich M, Ehrlich H, Färber L, Hunstein W.
    Bone Marrow Transplant; 1993 Dec 30; 12(6):643-9. PubMed ID: 7511017
    [Abstract] [Full Text] [Related]

  • 16. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
    Hill GR, Inder A, Patton WN, Hart DN.
    N Z Med J; 1996 Feb 23; 109(1016):45-8. PubMed ID: 8598936
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 23; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 18. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R, Klingebiel T, Niethammer D.
    Infusionsther Transfusionsmed; 1994 Nov 23; 21 Suppl 3():39-41. PubMed ID: 7841779
    [Abstract] [Full Text] [Related]

  • 19. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A, Takeyama K, Narabayashi M, Okamoto R, Adachi I, Tobinai K, Shimoyama M.
    Bone Marrow Transplant; 1995 Jan 23; 15(1):49-54. PubMed ID: 7538002
    [Abstract] [Full Text] [Related]

  • 20. Collection and use of circulating hematopoietic progenitor cells.
    Lee JH, Klein HG.
    Hematol Oncol Clin North Am; 1995 Feb 23; 9(1):1-22. PubMed ID: 7737936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.